A Randomised trial comparing the efficacy of intravitreal dexamethasone implant in the management of Idiopathic ERM

Pars Plana Vitrectomy with or Without Intravitreal Dexamethasone Implant for Idiopathic Epiretinal Membrane in Pseudophakic Eyes: A Randomized Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110584

Enrollment

Registered

2026-05-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole

Interventions

Intervention1: Pars plana vitrectomy with Dexamethasone implant: addition of Dexamethasone implant at the end of PPV which is the standard procedure Intervention2: Pars plana vitrectomy for Idiopathic

Eligibility

Inclusion criteria

Inclusion criteria: patients who have undergone uncomplicated cataract surgery and has idiopathic ERM

Exclusion criteria

Exclusion criteria: participants younger than 40 years of age and any other ocular comorbidities

Design outcomes

Primary

Measure	Time frame
Visual prognosis following ERM & ILM peeling with and without intravitreal dexamethasone implant. Timepoint: 1st 3rd and 6th month	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactAnjana

The Eye Foundation

vitbuckler@gmail.com8147059510

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026